VIDILI, Gianpaolo
 Distribuzione geografica
Continente #
NA - Nord America 3.343
AS - Asia 2.291
SA - Sud America 1.621
EU - Europa 1.200
AF - Africa 97
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.571
Nazione #
US - Stati Uniti d'America 3.239
BR - Brasile 1.455
SG - Singapore 1.120
CN - Cina 577
UA - Ucraina 309
IT - Italia 248
HK - Hong Kong 170
DE - Germania 164
VN - Vietnam 96
SE - Svezia 90
FI - Finlandia 88
RU - Federazione Russa 71
GB - Regno Unito 68
AR - Argentina 61
TR - Turchia 45
IQ - Iraq 40
BD - Bangladesh 39
CA - Canada 38
IN - India 34
MX - Messico 34
ZA - Sudafrica 29
EC - Ecuador 28
ID - Indonesia 26
MA - Marocco 26
FR - Francia 22
JP - Giappone 20
VE - Venezuela 20
UZ - Uzbekistan 19
CO - Colombia 17
AT - Austria 16
BE - Belgio 16
CZ - Repubblica Ceca 16
PL - Polonia 15
PK - Pakistan 14
RO - Romania 14
ES - Italia 13
KR - Corea 13
AU - Australia 12
NL - Olanda 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
CL - Cile 9
PY - Paraguay 9
UY - Uruguay 9
AL - Albania 8
CI - Costa d'Avorio 8
JO - Giordania 8
AZ - Azerbaigian 7
BO - Bolivia 7
HN - Honduras 7
LT - Lituania 7
CR - Costa Rica 6
JM - Giamaica 6
PE - Perù 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
IL - Israele 5
NP - Nepal 5
BN - Brunei Darussalam 4
DZ - Algeria 4
IR - Iran 4
KZ - Kazakistan 4
LB - Libano 4
SN - Senegal 4
BH - Bahrain 3
CH - Svizzera 3
EE - Estonia 3
KG - Kirghizistan 3
KW - Kuwait 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CY - Cipro 2
EG - Egitto 2
GE - Georgia 2
IE - Irlanda 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MW - Malawi 1
NE - Niger 1
Totale 8.562
Città #
Dallas 1.281
Singapore 573
Chandler 420
Jacksonville 177
Hong Kong 167
Beijing 163
Princeton 147
Ashburn 131
São Paulo 102
Nanjing 82
Sassari 70
Dearborn 69
Ann Arbor 57
Shanghai 54
Belo Horizonte 52
Rio de Janeiro 52
Helsinki 48
Wilmington 43
Los Angeles 42
Ho Chi Minh City 40
New York 38
Boardman 30
Moscow 29
Santa Clara 29
Brasília 28
Nanchang 28
Shenyang 26
Munich 23
Curitiba 22
Woodbridge 21
Porto Alegre 20
Tianjin 20
Nuremberg 19
Tokyo 19
Columbus 18
Brooklyn 17
Changsha 17
Tashkent 17
Brno 16
Hanoi 16
Brussels 15
Mountain View 15
Warsaw 15
Atlanta 14
Johannesburg 14
Milan 14
Baghdad 13
Council Bluffs 12
Guangzhou 12
Hebei 12
Houston 12
London 12
Salvador 12
Seoul 12
Campo Grande 11
Guarulhos 11
Guayaquil 11
Izmir 11
Jiaxing 11
Jinan 11
Ribeirão Preto 11
Santo André 11
Sarapul 11
Stockholm 11
The Dalles 11
Toronto 11
Vienna 11
Andover 10
Campinas 10
Franca 10
Montreal 10
Nairobi 10
Ottawa 10
Poplar 10
San Francisco 10
Ankara 9
Betim 9
Buffalo 9
Denver 9
Fortaleza 9
Frankfurt am Main 9
Goiânia 9
Mauá 9
Montevideo 9
Recife 9
São José dos Campos 9
Abidjan 8
Amman 8
Auburn Hills 8
Bogotá 8
Chennai 8
Joinville 8
Juiz de Fora 8
Mexico City 8
Ningbo 8
Quito 8
Rome 8
São Bernardo do Campo 8
Baku 7
Boydton 7
Totale 4.839
Nome #
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 324
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 168
Bedside ultrasonography (US), Echoscopy and US point of care as a new kind of stethoscope for Internal Medicine Departments: the training program of the Italian Internal Medicine Society (SIMI). 166
INVECCHIAMENTO E SISTEMA ENDOCRINO.LA SOMATOPAUSA, LA ADRENOPAUSA, LE MALATTIE DELLA TIROIDE 161
Characterization of focal liver lesions with contrast-enhanced ultrasound. 160
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 157
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 156
Evaluation of EZH2 expression in hepatitis B patients 149
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 146
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 139
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 139
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis Results of an International Registry 137
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. 132
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents 128
Clinical pattern of celiac disease in a population residing in North Sardinia (Italy) 128
A Case of thyroid metastasis from pancreatic cancer: case report and literature review 126
Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography 126
Clinical history of cancer-associated splanchnic vein thrombosis 122
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications. 121
Fitz-Hugh-Curtis-syndrome mimicking acute cholecystitis: value of new ultrasound findings in the differential diagnosis 115
Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a retrospective Cohort Study 114
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 114
Antithrombotic treatment of splanchnic vein thrombosis: Results of an international registry 113
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 112
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 112
Clinical presentation, diagnosis, and staging of cholangiocarcinoma 111
Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: a cross-sectional controlled study with real-time two-dimensional shear wave elastography 111
Experience of high frequency ultrasound in rare scalp pathology 111
Focal nodular hyperplasia: new findings at Doppler ultrasonography 110
Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver 106
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 103
Surgical treatment of chronic multivascular mesenteric ischemia in a patient with antiphospholipid syndrome, abdominal aortic aneurism, and renal cancer: when planning overwhelms complexity Ann Ital Chir. 2016 Dec 20;5. pii: S2239253X16026104. PMID: 27941240 102
HCC: Identificazione e caratterizzazione ecografica 100
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 97
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 97
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 96
Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma 93
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease 92
Common Variable Immunodeficiency and Selective IgA Deficiency: Focus on Autoimmune Manifestations and Their Pathogenesis 92
Sorafenib and locoregional treatment in patients with stage B and stage C HCC: Sardinian experience 89
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. 89
Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study 89
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 88
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 87
The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. 86
Diagnosis and management of hepatic focal nodular hyperplasia. Journal of Ultrasound 85
Contrast-enhanced ultrasonography features of extramedullary hematopoiesis presenting as a presacral mass: an update of the literature. 84
Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study 84
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 82
Trapianto di fegato 82
Pathophysiological roles, molecular interactions and clinical implications of long non-coding RNA CCAT2 in human cancer 82
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 80
Renal hemodynamics and renoprotection 79
RASi therapy in the renal haemodynamic in the course of proteinuric chronic nephropathy 79
Ipertensione portale: aspetti eco-color-Doppler 78
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 78
Usefulness of ultrasound in the diagnosis of peritoneal tuberculosis 78
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 78
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 76
Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients 76
Doppler US and contrast-enhanced perfusional angiosonography in hepatocellular carcinoma 74
Usefulness of ultrasound in the diagnosis of peritoneal tuberculosis 74
Inverse association between glucose‒6‒phosphate dehydrogenase deficiency and hepatocellular carcinoma 73
Identification of clinical phenotypes and related survival in patients with large hccs 73
SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease 70
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 70
The changing scenario of hepatocellular carcinoma in Italy: an update 69
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 68
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis 67
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma 66
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 66
Fisica, tecnica e principi di applicazione dell'eco-Doppler in medicina 65
Role of Lung Ultrasound in the Management of Patients with Suspected SARS-CoV-2 Infection in the Emergency Department 65
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 65
linical pattern of celiac disease in a population residing in North Sardinia (Italy 64
Gastrointestinal Ultrasound in Emergency Setting 64
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation 63
Non-invasive tools for the prediction of esophageal varices in cirrhosis: Can advanced ultrasound techniques spare endoscopy? 63
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 62
An ultrasound-based approach to jaundice from diagnosis to treatment 61
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 60
Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations 59
SIUMB recommendations for focal pancreatic lesions 59
Monofocal hepatocellular carcinoma: How much does size matter? 56
Pattern of macrovascular invasion in hepatocellular carcinoma 56
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 53
Subclinical hyperthyroidism: The cardiovascular point of view 51
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 51
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review 50
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 48
Infectious Pneumonia and Lung Ultrasound: A Review 43
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 42
SIUMB recommendations on the use of ultrasound in neoplastic lesions of the gallbladder and extrahepatic biliary tract 22
null 10
null 5
Totale 8.722
Categoria #
all - tutte 36.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.201


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021251 0 0 0 0 0 16 60 11 65 68 22 9
2021/2022352 43 14 2 5 4 4 20 13 24 13 68 142
2022/2023774 80 69 17 131 74 122 0 90 124 8 34 25
2023/2024326 35 14 11 13 38 18 13 43 2 5 25 109
2024/20252.942 43 50 139 90 153 100 176 532 1.044 411 121 83
2025/20262.948 203 1.033 611 625 441 35 0 0 0 0 0 0
Totale 8.722